2017
DOI: 10.1016/j.taap.2016.12.004
|View full text |Cite
|
Sign up to set email alerts
|

The anti-ALS drug riluzole attenuates pericyte loss in the diabetic retinopathy of streptozotocin-treated mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 44 publications
0
14
0
Order By: Relevance
“…Increased fluorescein leakage was observed at a late phase in retinas of STZ diabetic mice, compared with controls, which was significantly attenuated upon UDCA treatment (Figures 1(a) and 1(b)). To evaluate the effect of UDCA on retinal microvasculature in diabetic mice, we measured the linear capillary density by counting the number of capillaries intersected by a 500  μ m line on fluorescein isothiocyanate (FITC) images at 8 weeks after STZ injection [36, 37]. Linear capillary density was decreased in nontreated diabetic mice, compared with controls, but not in UDCA-treated mice (Figures 2(a) and 2(b)).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Increased fluorescein leakage was observed at a late phase in retinas of STZ diabetic mice, compared with controls, which was significantly attenuated upon UDCA treatment (Figures 1(a) and 1(b)). To evaluate the effect of UDCA on retinal microvasculature in diabetic mice, we measured the linear capillary density by counting the number of capillaries intersected by a 500  μ m line on fluorescein isothiocyanate (FITC) images at 8 weeks after STZ injection [36, 37]. Linear capillary density was decreased in nontreated diabetic mice, compared with controls, but not in UDCA-treated mice (Figures 2(a) and 2(b)).…”
Section: Resultsmentioning
confidence: 99%
“…We sacrificed mice 8 weeks after STZ injection, when we evaluated as the time-point of prominent vascular change, from our previous experiment [36]. Anesthesia was performed via intramuscular injection of 0.3 ml of Zoletil (diluted 1 : 5) and cardiac perfusion with 0.5 ml of 15 mg/ml fluorescein-dextran (2,000 kDa, #FD2000S, Sigma).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…However, these therapies are often started in late stages of DR, and are designed to prevent further deterioration rather than restore impaired vision [70]. On the other hand, intensive treatment of diabetes may prevent onset and progression of DR as shown by the Diabetes Control and Complications Trial (DCCT) and UKPDS studies [71].…”
Section: Therapeutic Viewpointsmentioning
confidence: 99%